img

Global Therapeutic Recombinant Protein Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Therapeutic Recombinant Protein Market Insights, Forecast to 2034

Therapeutic recombinant proteins are proteins that are produced by recombinant DNA technology and are used as drugs to treat various medical conditions. Recombinant DNA technology involves the use of genetically engineered microorganisms or cells to produce large quantities of a specific protein that has therapeutic potential. Therapeutic recombinant proteins are used to treat a wide range of medical conditions, including cancer, autoimmune diseases, genetic disorders, and infectious diseases. These proteins are designed to mimic the natural proteins in the body that regulate various biological processes. They are often administered by injection, and their effectiveness depends on the specific protein and the medical condition being treated.
Market Analysis and InsightsGlobal Therapeutic Recombinant Protein Market
Global Therapeutic Recombinant Protein market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Therapeutic Recombinant Protein industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Therapeutic Recombinant Protein market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Therapeutic Recombinant Protein market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Abcam
HALIX
Avantor
Miltenyi Biotec
Thermo Fisher Scientific
Bio-Techne Corporation
Merck
ACROBiosystems
Abnova
Eurogentec (Kaneka Corporation)
Cytiva (Danaher )
Reprocell
GenScript
BPS Bioscience
Sino Biological
Segment by Type
Hormones
Blood Clotting Factors
Cytokines
Enzymes
Fusion Proteins
Others

Segment by Application


Pharmaceutical Company
Research Institute
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Therapeutic Recombinant Protein introduction, etc. Therapeutic Recombinant Protein Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Therapeutic Recombinant Protein
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Therapeutic Recombinant Protein Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Hormones
1.2.3 Blood Clotting Factors
1.2.4 Cytokines
1.2.5 Enzymes
1.2.6 Fusion Proteins
1.2.7 Others
1.3 Market by Application
1.3.1 Global Therapeutic Recombinant Protein Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Pharmaceutical Company
1.3.3 Research Institute
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Therapeutic Recombinant Protein Market Perspective (2018-2033)
2.2 Global Therapeutic Recombinant Protein Growth Trends by Region
2.2.1 Therapeutic Recombinant Protein Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Therapeutic Recombinant Protein Historic Market Size by Region (2018-2023)
2.2.3 Therapeutic Recombinant Protein Forecasted Market Size by Region (2024-2033)
2.3 Therapeutic Recombinant Protein Market Dynamics
2.3.1 Therapeutic Recombinant Protein Industry Trends
2.3.2 Therapeutic Recombinant Protein Market Drivers
2.3.3 Therapeutic Recombinant Protein Market Challenges
2.3.4 Therapeutic Recombinant Protein Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Therapeutic Recombinant Protein by Players
3.1.1 Global Therapeutic Recombinant Protein Revenue by Players (2018-2023)
3.1.2 Global Therapeutic Recombinant Protein Revenue Market Share by Players (2018-2023)
3.2 Global Therapeutic Recombinant Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Therapeutic Recombinant Protein, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Therapeutic Recombinant Protein Market Concentration Ratio
3.4.1 Global Therapeutic Recombinant Protein Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Recombinant Protein Revenue in 2022
3.5 Global Key Players of Therapeutic Recombinant Protein Head office and Area Served
3.6 Global Key Players of Therapeutic Recombinant Protein, Product and Application
3.7 Global Key Players of Therapeutic Recombinant Protein, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Therapeutic Recombinant Protein Breakdown Data by Type
4.1 Global Therapeutic Recombinant Protein Historic Market Size by Type (2018-2023)
4.2 Global Therapeutic Recombinant Protein Forecasted Market Size by Type (2024-2033)
5 Therapeutic Recombinant Protein Breakdown Data by Application
5.1 Global Therapeutic Recombinant Protein Historic Market Size by Application (2018-2023)
5.2 Global Therapeutic Recombinant Protein Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Therapeutic Recombinant Protein Market Size (2018-2033)
6.2 North America Therapeutic Recombinant Protein Market Size by Type
6.2.1 North America Therapeutic Recombinant Protein Market Size by Type (2018-2023)
6.2.2 North America Therapeutic Recombinant Protein Market Size by Type (2024-2033)
6.2.3 North America Therapeutic Recombinant Protein Market Share by Type (2018-2033)
6.3 North America Therapeutic Recombinant Protein Market Size by Application
6.3.1 North America Therapeutic Recombinant Protein Market Size by Application (2018-2023)
6.3.2 North America Therapeutic Recombinant Protein Market Size by Application (2024-2033)
6.3.3 North America Therapeutic Recombinant Protein Market Share by Application (2018-2033)
6.4 North America Therapeutic Recombinant Protein Market Size by Country
6.4.1 North America Therapeutic Recombinant Protein Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Therapeutic Recombinant Protein Market Size by Country (2018-2023)
6.4.3 North America Therapeutic Recombinant Protein Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Therapeutic Recombinant Protein Market Size (2018-2033)
7.2 Europe Therapeutic Recombinant Protein Market Size by Type
7.2.1 Europe Therapeutic Recombinant Protein Market Size by Type (2018-2023)
7.2.2 Europe Therapeutic Recombinant Protein Market Size by Type (2024-2033)
7.2.3 Europe Therapeutic Recombinant Protein Market Share by Type (2018-2033)
7.3 Europe Therapeutic Recombinant Protein Market Size by Application
7.3.1 Europe Therapeutic Recombinant Protein Market Size by Application (2018-2023)
7.3.2 Europe Therapeutic Recombinant Protein Market Size by Application (2024-2033)
7.3.3 Europe Therapeutic Recombinant Protein Market Share by Application (2018-2033)
7.4 Europe Therapeutic Recombinant Protein Market Size by Country
7.4.1 Europe Therapeutic Recombinant Protein Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Therapeutic Recombinant Protein Market Size by Country (2018-2023)
7.4.3 Europe Therapeutic Recombinant Protein Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Therapeutic Recombinant Protein Market Size (2018-2033)
8.2 China Therapeutic Recombinant Protein Market Size by Type
8.2.1 China Therapeutic Recombinant Protein Market Size by Type (2018-2023)
8.2.2 China Therapeutic Recombinant Protein Market Size by Type (2024-2033)
8.2.3 China Therapeutic Recombinant Protein Market Share by Type (2018-2033)
8.3 China Therapeutic Recombinant Protein Market Size by Application
8.3.1 China Therapeutic Recombinant Protein Market Size by Application (2018-2023)
8.3.2 China Therapeutic Recombinant Protein Market Size by Application (2024-2033)
8.3.3 China Therapeutic Recombinant Protein Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Therapeutic Recombinant Protein Market Size (2018-2033)
9.2 Asia Therapeutic Recombinant Protein Market Size by Type
9.2.1 Asia Therapeutic Recombinant Protein Market Size by Type (2018-2023)
9.2.2 Asia Therapeutic Recombinant Protein Market Size by Type (2024-2033)
9.2.3 Asia Therapeutic Recombinant Protein Market Share by Type (2018-2033)
9.3 Asia Therapeutic Recombinant Protein Market Size by Application
9.3.1 Asia Therapeutic Recombinant Protein Market Size by Application (2018-2023)
9.3.2 Asia Therapeutic Recombinant Protein Market Size by Application (2024-2033)
9.3.3 Asia Therapeutic Recombinant Protein Market Share by Application (2018-2033)
9.4 Asia Therapeutic Recombinant Protein Market Size by Region
9.4.1 Asia Therapeutic Recombinant Protein Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Therapeutic Recombinant Protein Market Size by Region (2018-2023)
9.4.3 Asia Therapeutic Recombinant Protein Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Therapeutic Recombinant Protein Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Therapeutic Recombinant Protein Market Size by Type
10.2.1 Middle East, Africa, and Latin America Therapeutic Recombinant Protein Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Therapeutic Recombinant Protein Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Therapeutic Recombinant Protein Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Therapeutic Recombinant Protein Market Size by Application
10.3.1 Middle East, Africa, and Latin America Therapeutic Recombinant Protein Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Therapeutic Recombinant Protein Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Therapeutic Recombinant Protein Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Therapeutic Recombinant Protein Market Size by Country
10.4.1 Middle East, Africa, and Latin America Therapeutic Recombinant Protein Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Therapeutic Recombinant Protein Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Therapeutic Recombinant Protein Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Details
11.1.2 Abcam Business Overview
11.1.3 Abcam Therapeutic Recombinant Protein Introduction
11.1.4 Abcam Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.1.5 Abcam Recent Developments
11.2 HALIX
11.2.1 HALIX Company Details
11.2.2 HALIX Business Overview
11.2.3 HALIX Therapeutic Recombinant Protein Introduction
11.2.4 HALIX Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.2.5 HALIX Recent Developments
11.3 Avantor
11.3.1 Avantor Company Details
11.3.2 Avantor Business Overview
11.3.3 Avantor Therapeutic Recombinant Protein Introduction
11.3.4 Avantor Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.3.5 Avantor Recent Developments
11.4 Miltenyi Biotec
11.4.1 Miltenyi Biotec Company Details
11.4.2 Miltenyi Biotec Business Overview
11.4.3 Miltenyi Biotec Therapeutic Recombinant Protein Introduction
11.4.4 Miltenyi Biotec Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.4.5 Miltenyi Biotec Recent Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Therapeutic Recombinant Protein Introduction
11.5.4 Thermo Fisher Scientific Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.5.5 Thermo Fisher Scientific Recent Developments
11.6 Bio-Techne Corporation
11.6.1 Bio-Techne Corporation Company Details
11.6.2 Bio-Techne Corporation Business Overview
11.6.3 Bio-Techne Corporation Therapeutic Recombinant Protein Introduction
11.6.4 Bio-Techne Corporation Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.6.5 Bio-Techne Corporation Recent Developments
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Therapeutic Recombinant Protein Introduction
11.7.4 Merck Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.7.5 Merck Recent Developments
11.8 ACROBiosystems
11.8.1 ACROBiosystems Company Details
11.8.2 ACROBiosystems Business Overview
11.8.3 ACROBiosystems Therapeutic Recombinant Protein Introduction
11.8.4 ACROBiosystems Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.8.5 ACROBiosystems Recent Developments
11.9 Abnova
11.9.1 Abnova Company Details
11.9.2 Abnova Business Overview
11.9.3 Abnova Therapeutic Recombinant Protein Introduction
11.9.4 Abnova Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.9.5 Abnova Recent Developments
11.10 Eurogentec (Kaneka Corporation)
11.10.1 Eurogentec (Kaneka Corporation) Company Details
11.10.2 Eurogentec (Kaneka Corporation) Business Overview
11.10.3 Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Introduction
11.10.4 Eurogentec (Kaneka Corporation) Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.10.5 Eurogentec (Kaneka Corporation) Recent Developments
11.11 Cytiva (Danaher )
11.11.1 Cytiva (Danaher ) Company Details
11.11.2 Cytiva (Danaher ) Business Overview
11.11.3 Cytiva (Danaher ) Therapeutic Recombinant Protein Introduction
11.11.4 Cytiva (Danaher ) Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.11.5 Cytiva (Danaher ) Recent Developments
11.12 Reprocell
11.12.1 Reprocell Company Details
11.12.2 Reprocell Business Overview
11.12.3 Reprocell Therapeutic Recombinant Protein Introduction
11.12.4 Reprocell Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.12.5 Reprocell Recent Developments
11.13 GenScript
11.13.1 GenScript Company Details
11.13.2 GenScript Business Overview
11.13.3 GenScript Therapeutic Recombinant Protein Introduction
11.13.4 GenScript Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.13.5 GenScript Recent Developments
11.14 BPS Bioscience
11.14.1 BPS Bioscience Company Details
11.14.2 BPS Bioscience Business Overview
11.14.3 BPS Bioscience Therapeutic Recombinant Protein Introduction
11.14.4 BPS Bioscience Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.14.5 BPS Bioscience Recent Developments
11.15 Sino Biological
11.15.1 Sino Biological Company Details
11.15.2 Sino Biological Business Overview
11.15.3 Sino Biological Therapeutic Recombinant Protein Introduction
11.15.4 Sino Biological Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.15.5 Sino Biological Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Therapeutic Recombinant Protein Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Hormones
Table 3. Key Players of Blood Clotting Factors
Table 4. Key Players of Cytokines
Table 5. Key Players of Enzymes
Table 6. Key Players of Fusion Proteins
Table 7. Key Players of Others
Table 8. Global Therapeutic Recombinant Protein Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 9. Global Therapeutic Recombinant Protein Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Therapeutic Recombinant Protein Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Therapeutic Recombinant Protein Market Share by Region (2018-2023)
Table 12. Global Therapeutic Recombinant Protein Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global Therapeutic Recombinant Protein Market Share by Region (2024-2033)
Table 14. Therapeutic Recombinant Protein Market Trends
Table 15. Therapeutic Recombinant Protein Market Drivers
Table 16. Therapeutic Recombinant Protein Market Challenges
Table 17. Therapeutic Recombinant Protein Market Restraints
Table 18. Global Therapeutic Recombinant Protein Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Therapeutic Recombinant Protein Revenue Share by Players (2018-2023)
Table 20. Global Top Therapeutic Recombinant Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Recombinant Protein as of 2022)
Table 21. Global Therapeutic Recombinant Protein Industry Ranking 2021 VS 2022 VS 2023
Table 22. Global 5 Largest Players Market Share by Therapeutic Recombinant Protein Revenue (CR5 and HHI) & (2018-2023)
Table 23. Global Key Players of Therapeutic Recombinant Protein, Headquarters and Area Served
Table 24. Global Key Players of Therapeutic Recombinant Protein, Product and Application
Table 25. Global Key Players of Therapeutic Recombinant Protein, Product and Application
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Therapeutic Recombinant Protein Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Therapeutic Recombinant Protein Revenue Market Share by Type (2018-2023)
Table 29. Global Therapeutic Recombinant Protein Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global Therapeutic Recombinant Protein Revenue Market Share by Type (2024-2033)
Table 31. Global Therapeutic Recombinant Protein Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Therapeutic Recombinant Protein Revenue Share by Application (2018-2023)
Table 33. Global Therapeutic Recombinant Protein Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global Therapeutic Recombinant Protein Revenue Share by Application (2024-2033)
Table 35. North America Therapeutic Recombinant Protein Market Size by Type (2018-2023) & (US$ Million)
Table 36. North America Therapeutic Recombinant Protein Market Size by Type (2024-2033) & (US$ Million)
Table 37. North America Therapeutic Recombinant Protein Market Size by Application (2018-2023) & (US$ Million)
Table 38. North America Therapeutic Recombinant Protein Market Size by Application (2024-2033) & (US$ Million)
Table 39. North America Therapeutic Recombinant Protein Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 40. North America Therapeutic Recombinant Protein Market Size by Country (2018-2023) & (US$ Million)
Table 41. North America Therapeutic Recombinant Protein Market Size by Country (2024-2033) & (US$ Million)
Table 42. Europe Therapeutic Recombinant Protein Market Size by Type (2018-2023) & (US$ Million)
Table 43. Europe Therapeutic Recombinant Protein Market Size by Type (2024-2033) & (US$ Million)
Table 44. Europe Therapeutic Recombinant Protein Market Size by Application (2018-2023) & (US$ Million)
Table 45. Europe Therapeutic Recombinant Protein Market Size by Application (2024-2033) & (US$ Million)
Table 46. Europe Therapeutic Recombinant Protein Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Europe Therapeutic Recombinant Protein Market Size by Country (2018-2023) & (US$ Million)
Table 48. Europe Therapeutic Recombinant Protein Market Size by Country (2024-2033) & (US$ Million)
Table 49. China Therapeutic Recombinant Protein Market Size by Type (2018-2023) & (US$ Million)
Table 50. China Therapeutic Recombinant Protein Market Size by Type (2024-2033) & (US$ Million)
Table 51. China Therapeutic Recombinant Protein Market Size by Application (2018-2023) & (US$ Million)
Table 52. China Therapeutic Recombinant Protein Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Therapeutic Recombinant Protein Market Size by Type (2018-2023) & (US$ Million)
Table 54. Asia Therapeutic Recombinant Protein Market Size by Type (2024-2033) & (US$ Million)
Table 55. Asia Therapeutic Recombinant Protein Market Size by Application (2018-2023) & (US$ Million)
Table 56. Asia Therapeutic Recombinant Protein Market Size by Application (2024-2033) & (US$ Million)
Table 57. Asia Therapeutic Recombinant Protein Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 58. Asia Therapeutic Recombinant Protein Market Size by Region (2018-2023) & (US$ Million)
Table 59. Asia Therapeutic Recombinant Protein Market Size by Region (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Therapeutic Recombinant Protein Market Size by Type (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Therapeutic Recombinant Protein Market Size by Type (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Therapeutic Recombinant Protein Market Size by Application (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Therapeutic Recombinant Protein Market Size by Application (2024-2033) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Therapeutic Recombinant Protein Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 65. Middle East, Africa, and Latin America Therapeutic Recombinant Protein Market Size by Country (2018-2023) & (US$ Million)
Table 66. Middle East, Africa, and Latin America Therapeutic Recombinant Protein Market Size by Country (2024-2033) & (US$ Million)
Table 67. Abcam Company Details
Table 68. Abcam Business Overview
Table 69. Abcam Therapeutic Recombinant Protein Product
Table 70. Abcam Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 71. Abcam Recent Developments
Table 72. HALIX Company Details
Table 73. HALIX Business Overview
Table 74. HALIX Therapeutic Recombinant Protein Product
Table 75. HALIX Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 76. HALIX Recent Developments
Table 77. Avantor Company Details
Table 78. Avantor Business Overview
Table 79. Avantor Therapeutic Recombinant Protein Product
Table 80. Avantor Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 81. Avantor Recent Developments
Table 82. Miltenyi Biotec Company Details
Table 83. Miltenyi Biotec Business Overview
Table 84. Miltenyi Biotec Therapeutic Recombinant Protein Product
Table 85. Miltenyi Biotec Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 86. Miltenyi Biotec Recent Developments
Table 87. Thermo Fisher Scientific Company Details
Table 88. Thermo Fisher Scientific Business Overview
Table 89. Thermo Fisher Scientific Therapeutic Recombinant Protein Product
Table 90. Thermo Fisher Scientific Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 91. Thermo Fisher Scientific Recent Developments
Table 92. Bio-Techne Corporation Company Details
Table 93. Bio-Techne Corporation Business Overview
Table 94. Bio-Techne Corporation Therapeutic Recombinant Protein Product
Table 95. Bio-Techne Corporation Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 96. Bio-Techne Corporation Recent Developments
Table 97. Merck Company Details
Table 98. Merck Business Overview
Table 99. Merck Therapeutic Recombinant Protein Product
Table 100. Merck Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 101. Merck Recent Developments
Table 102. ACROBiosystems Company Details
Table 103. ACROBiosystems Business Overview
Table 104. ACROBiosystems Therapeutic Recombinant Protein Product
Table 105. ACROBiosystems Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 106. ACROBiosystems Recent Developments
Table 107. Abnova Company Details
Table 108. Abnova Business Overview
Table 109. Abnova Therapeutic Recombinant Protein Product
Table 110. Abnova Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 111. Abnova Recent Developments
Table 112. Eurogentec (Kaneka Corporation) Company Details
Table 113. Eurogentec (Kaneka Corporation) Business Overview
Table 114. Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Product
Table 115. Eurogentec (Kaneka Corporation) Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 116. Eurogentec (Kaneka Corporation) Recent Developments
Table 117. Cytiva (Danaher ) Company Details
Table 118. Cytiva (Danaher ) Business Overview
Table 119. Cytiva (Danaher ) Therapeutic Recombinant Protein Product
Table 120. Cytiva (Danaher ) Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 121. Cytiva (Danaher ) Recent Developments
Table 122. Reprocell Company Details
Table 123. Reprocell Business Overview
Table 124. Reprocell Therapeutic Recombinant Protein Product
Table 125. Reprocell Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 126. Reprocell Recent Developments
Table 127. GenScript Company Details
Table 128. GenScript Business Overview
Table 129. GenScript Therapeutic Recombinant Protein Product
Table 130. GenScript Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 131. GenScript Recent Developments
Table 132. BPS Bioscience Company Details
Table 133. BPS Bioscience Business Overview
Table 134. BPS Bioscience Therapeutic Recombinant Protein Product
Table 135. BPS Bioscience Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 136. BPS Bioscience Recent Developments
Table 137. Sino Biological Company Details
Table 138. Sino Biological Business Overview
Table 139. Sino Biological Therapeutic Recombinant Protein Product
Table 140. Sino Biological Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 141. Sino Biological Recent Developments
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Therapeutic Recombinant Protein Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Therapeutic Recombinant Protein Market Share by Type: 2022 VS 2033
Figure 3. Hormones Features
Figure 4. Blood Clotting Factors Features
Figure 5. Cytokines Features
Figure 6. Enzymes Features
Figure 7. Fusion Proteins Features
Figure 8. Others Features
Figure 9. Global Therapeutic Recombinant Protein Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 10. Global Therapeutic Recombinant Protein Market Share by Application: 2022 VS 2033
Figure 11. Pharmaceutical Company Case Studies
Figure 12. Research Institute Case Studies
Figure 13. Others Case Studies
Figure 14. Therapeutic Recombinant Protein Report Years Considered
Figure 15. Global Therapeutic Recombinant Protein Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Therapeutic Recombinant Protein Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Therapeutic Recombinant Protein Market Share by Region: 2022 VS 2033
Figure 18. Global Therapeutic Recombinant Protein Market Share by Players in 2022
Figure 19. Global Top Therapeutic Recombinant Protein Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Recombinant Protein as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Therapeutic Recombinant Protein Revenue in 2022
Figure 21. North America Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Therapeutic Recombinant Protein Market Share by Type (2018-2033)
Figure 23. North America Therapeutic Recombinant Protein Market Share by Application (2018-2033)
Figure 24. North America Therapeutic Recombinant Protein Market Share by Country (2018-2033)
Figure 25. United States Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Therapeutic Recombinant Protein Market Size YoY (2018-2033) & (US$ Million)
Figure 28. Europe Therapeutic Recombinant Protein Market Share by Type (2018-2033)
Figure 29. Europe Therapeutic Recombinant Protein Market Share by Application (2018-2033)
Figure 30. Europe Therapeutic Recombinant Protein Market Share by Country (2018-2033)
Figure 31. Germany Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. France Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. U.K. Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Italy Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Russia Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Nordic Countries Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. China Therapeutic Recombinant Protein Market Size YoY (2018-2033) & (US$ Million)
Figure 38. China Therapeutic Recombinant Protein Market Share by Type (2018-2033)
Figure 39. China Therapeutic Recombinant Protein Market Share by Application (2018-2033)
Figure 40. Asia Therapeutic Recombinant Protein Market Size YoY (2018-2033) & (US$ Million)
Figure 41. Asia Therapeutic Recombinant Protein Market Share by Type (2018-2033)
Figure 42. Asia Therapeutic Recombinant Protein Market Share by Application (2018-2033)
Figure 43. Asia Therapeutic Recombinant Protein Market Share by Region (2018-2033)
Figure 44. Japan Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. South Korea Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. China Taiwan Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Southeast Asia Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. India Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Australia Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Therapeutic Recombinant Protein Market Size YoY (2018-2033) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Therapeutic Recombinant Protein Market Share by Type (2018-2033)
Figure 52. Middle East, Africa, and Latin America Therapeutic Recombinant Protein Market Share by Application (2018-2033)
Figure 53. Middle East, Africa, and Latin America Therapeutic Recombinant Protein Market Share by Country (2018-2033)
Figure 54. Brazil Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Mexico Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Turkey Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Saudi Arabia Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Israel Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. GCC Countries Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. Abcam Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 61. HALIX Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 62. Avantor Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 63. Miltenyi Biotec Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 64. Thermo Fisher Scientific Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 65. Bio-Techne Corporation Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 66. Merck Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 67. ACROBiosystems Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 68. Abnova Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 69. Eurogentec (Kaneka Corporation) Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 70. Cytiva (Danaher ) Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 71. Reprocell Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 72. GenScript Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 73. BPS Bioscience Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 74. Sino Biological Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries